CCCC
Price
$2.23
Change
+$0.04 (+1.83%)
Updated
Sep 26 closing price
Capitalization
158.71M
33 days until earnings call
CELC
Price
$50.60
Change
-$1.34 (-2.58%)
Updated
Sep 26 closing price
Capitalization
2.15B
51 days until earnings call
Interact to see
Advertisement

CCCC vs CELC

Header iconCCCC vs CELC Comparison
Open Charts CCCC vs CELCBanner chart's image
C4 Therapeutics
Price$2.23
Change+$0.04 (+1.83%)
Volume$1.76M
Capitalization158.71M
Celcuity
Price$50.60
Change-$1.34 (-2.58%)
Volume$977.81K
Capitalization2.15B
CCCC vs CELC Comparison Chart in %
Loading...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CELC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CCCC vs. CELC commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCCC is a StrongBuy and CELC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (CCCC: $2.23 vs. CELC: $50.60)
Brand notoriety: CCCC and CELC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CCCC: 110% vs. CELC: 56%
Market capitalization -- CCCC: $158.71M vs. CELC: $2.15B
CCCC [@Biotechnology] is valued at $158.71M. CELC’s [@Biotechnology] market capitalization is $2.15B. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CCCC’s FA Score shows that 1 FA rating(s) are green whileCELC’s FA Score has 1 green FA rating(s).

  • CCCC’s FA Score: 1 green, 4 red.
  • CELC’s FA Score: 1 green, 4 red.
According to our system of comparison, CELC is a better buy in the long-term than CCCC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CCCC’s TA Score shows that 4 TA indicator(s) are bullish while CELC’s TA Score has 3 bullish TA indicator(s).

  • CCCC’s TA Score: 4 bullish, 6 bearish.
  • CELC’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both CCCC and CELC are a bad buy in the short-term.

Price Growth

CCCC (@Biotechnology) experienced а -29.43% price change this week, while CELC (@Biotechnology) price change was -2.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

CCCC is expected to report earnings on Oct 30, 2025.

CELC is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CELC($2.15B) has a higher market cap than CCCC($159M). CELC YTD gains are higher at: 286.555 vs. CCCC (-38.056). CCCC has higher annual earnings (EBITDA): -109.63M vs. CELC (-135.56M). CCCC has more cash in the bank: 215M vs. CELC (168M). CCCC has less debt than CELC: CCCC (62.9M) vs CELC (99.4M). CCCC has higher revenues than CELC: CCCC (34.2M) vs CELC (0).
CCCCCELCCCCC / CELC
Capitalization159M2.15B7%
EBITDA-109.63M-135.56M81%
Gain YTD-38.056286.555-13%
P/E RatioN/AN/A-
Revenue34.2M0-
Total Cash215M168M128%
Total Debt62.9M99.4M63%
FUNDAMENTALS RATINGS
CELC: Fundamental Ratings
CELC
OUTLOOK RATING
1..100
78
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
26
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
40

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CCCCCELC
RSI
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
86%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 6 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 23 days ago
83%
Bullish Trend 4 days ago
84%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 1 day ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
Aroon
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CELC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARBTF0.050.01
+18.02%
Argo Gold Inc
SVBT47.500.50
+1.06%
SVB&T Corporation
ACOPY5.73N/A
N/A
The A2 Milk Co Ltd.
BOIRF24.50N/A
N/A
Boiron
WIGBY60.42-1.56
-2.52%
Wisetech Global

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with BEAM. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
+1.83%
BEAM - CCCC
43%
Loosely correlated
-0.52%
OCUL - CCCC
40%
Loosely correlated
+2.37%
SYRE - CCCC
40%
Loosely correlated
+4.04%
RXRX - CCCC
39%
Loosely correlated
+1.94%
CELC - CCCC
39%
Loosely correlated
-2.58%
More

CELC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CELC has been closely correlated with IMA. These tickers have moved in lockstep 84% of the time. This A.I.-generated data suggests there is a high statistical probability that if CELC jumps, then IMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CELC
1D Price
Change %
CELC100%
-2.58%
IMA - CELC
84%
Closely correlated
-0.90%
NEVPF - CELC
61%
Loosely correlated
N/A
BEAM - CELC
45%
Loosely correlated
-0.52%
CLDX - CELC
44%
Loosely correlated
+3.52%
ABOS - CELC
43%
Loosely correlated
-4.05%
More